Craft

Kukje Pharma

Stock Price

₩5.5 K

2024-10-29

Market Capitalization

₩111.4 B

2024-10-29

Revenue

₩156.5 B

FY, 2024

Kukje Pharma Summary

Company Summary

Overview
Kukje Pharma is a company that manufactures and sells pharmaceutical products. It offers antidiabetics, adrenal corticosteroids, tetracycline, dermatology agents, antibiotics, and other products.
Type
Public
Status
Active
Founded
1959
HQ
Seongnam-si, KR | view all locations
Website
https://www.kukjepharm.co.kr
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Seongnam-si, Gyeonggi-do HQ

    Korea (Republic of)

    96-8 Yatap-ro, Bundang-gu

Kukje Pharma Financials

Summary Financials

Revenue (Q1, 2025)
₩41.5B
Gross profit (Q1, 2025)
₩23.0B
Net income (Q1, 2025)
₩1.9B
Cash (Q1, 2025)
₩9.9B
EBIT (Q1, 2025)
₩2.3B
Enterprise value
$130.9B

Footer menu